Journals / Diagnostic and Interventional Radiology / 2015 / Cilt: 21 - Sayı: 3

Therapeutic effects of transarterial infusion of lipiodol and ethanol in various ratios in a rabbit VX2 tumor model

Pages
241–246
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Optimal efficacy and safety was achieved with a lipiodol to ethanol volume ratio of 1:1.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSEWe aimed to evaluate the therapeutic effect and safety of transcatheter arterial embolization with various volume ratios of lipiodol and ethanol in a rabbit VX2 tumor model to iden-tify the optimal volume ratio.METHODSEighteen adult male New Zealand white rabbits implanted with VX2 tumors in their left liver lobes were randomly di-vided into six groups based on volume ratios of lipiodol to ethanol: group A, 3:1; group B, 2:1; group C, 1:1; group D, 1:2; group E, 1:3; and group F, 1:4.
📊
Key Findings & Data:Pre- and post-treatment unenhanced magnetic resonance imaging was used to de-tect tumor formation and evaluate tumor growth rates.
💡
Conclusion & Impact:Optimal efficacy and safety was achieved with a lipiodol to ethanol volume ratio of 1:1.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

PURPOSEWe aimed to evaluate the therapeutic effect and safety of transcatheter arterial embolization with various volume ratios of lipiodol and ethanol in a rabbit VX2 tumor model to iden-tify the optimal volume ratio.METHODSEighteen adult male New Zealand white rabbits implanted with VX2 tumors in their left liver lobes were randomly di-vided into six groups based on volume ratios of lipiodol to ethanol: group A, 3:1; group B, 2:1; group C, 1:1; group D, 1:2; group E, 1:3; and group F, 1:4. Pre- and post-treatment unenhanced magnetic resonance imaging was used to de-tect tumor formation and evaluate tumor growth rates. Liver samples were harvested one week after the procedure, and apoptosis index of tumor tissues was evaluated by pathologic examination and TUNEL assay.RESULTSTumor size decreased in groups B, C, and D, but increased in groups A, E, and F. Tumor growth rates in groups A-F were 0.40±0.03, -0.11±0.21, -0.08±0.09, -0.12±0.07, 0.06±0.12, and 0.05±0.09, respectively. The change in tumor size was significantly different in group A compared with the rest of the groups, but no significant difference was observed among groups B-F. Apoptosis indexes of the six groups were 4.7±2.1%, 6.7±2.1%, 11.7±3.1%, 11.0±2.0%, 10.7±3.2%, and 12±3%, respectively. Apoptosis index was significantly lower in group A compared with groups C-F (P < 0.05). Apoptosis index of group B was significantly lower than groups C and F. There was no significant difference among the other groups.CONCLUSIONThe volume ratios of lipiodol to ethanol ranging from 2:1 to 1:4 were equally effective, the ratios 2:1 and 1:3 had equal safety, and the ratios 1:1 and 1:2 indicated better long-term therapeutic effect. Increasing ethanol in the mixture caused more severe liver injury. Optimal efficacy and safety was achieved with a lipiodol to ethanol volume ratio of 1:1.

🔖

Cite This Article

GAO, F., QIAN, T., CHEN, M. Z., YIN, H. B., XU, Y. L. (2015). Therapeutic effects of transarterial infusion of lipiodol and ethanol in various ratios in a rabbit VX2 tumor model. Diagnostic and Interventional Radiology, Cilt: 21 - Sayı: 3, 241–246. https://ajindex.com/articles/350071

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005
  2. [CrossRef] Brown DB, Nikolic B, Covey AM, et al. Quality improvement guidelines for tran- shepatic arterial chemoembolization, em- bolization, and chemotherapeutic infu- sion for hepatic malignancy. J Vasc Interv Radiol 2012
  3. [CrossRef] Geschwind JF, Ramsey DE, Cleffken B, et al. Transcatheter arterial chemoemboli- zation of liver tumors: effects of emboli- zation protocol on injectable volume of chemotherapy and subsequent arterial patency. Cardiovasc Intervent Radiol 2003
  4. [CrossRef] Jaeger HJ, Mehring UM, Castaneda F, et al. Sequential trans-arterial chemo-embo- lization for unresectable advanced hepa- tocellular carcinoma. Cardiovasc Inter- vent Radiol 1996
  5. [CrossRef] Bruix J, Sherman M. Management of he- patocellular carcinoma. Hepatology 2005
  6. [CrossRef] O'Riordan D, McAllister H, Sheahan BJ, MacErlean DP. Hepatic infarction with absolute ethanol. Radiology 1984
  7. [CrossRef] Yu SC, Hui EP, Wong J, et al. Transarte- rial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II study. J Vasc Interv Radiol 2008
  8. [CrossRef] Yu SC, Hui JW, Hui EP, et al. Embolization efficacy and treatment effectiveness of tran- sarterial therapy for unresectable hepatocel- lular carcinoma: a case-controlled compar- ison of transarterial ethanol ablation with lipiodol-ethanol mixture versus transcath- eter arterial chemoembolization. J Vasc In- terv Radiol 2009
  9. [CrossRef] Kan Z, Wallace S. Transcatheter liver lobar abla- tion: an experimental trial in an animal model. Eur Radiol 1997
  10. [CrossRef] Lee KH, Liapi E, Ventura VP, et al. Evalua- tion of different calibrated spherical poly- vinyl alcohol microspheres in transcath- eter arterial chemoembolization: VX2 tumor model in rabbit liver. J Vasc Interv Radiol 2008
  11. [CrossRef] Nitta-Seko A, Nitta N, Sonoda A, et al. An- ti-tumour effects of transcatheter arterial embolisation administered in combina- tion with thalidomide in a rabbit VX2 liver tumour model. Br J Radiol 2011
  12. [CrossRef] Cao W, Wan Y, Liang ZH, et al. Heated lipiodol as an embolization agent for transhepatic arterial embolization in VX2 rabbit liver cancer model. Eur J Radiol 2010
  13. [CrossRef] Wang Y, Zheng C, Liang B, et al. Hepa- tocellular necrosis, apoptosis, and pro- liferation after trans